
Building MSL Teams Across Two Product Launches for a Global Biotech
Mix built a 50-person MSL team across two product launches for a global biotech, then filled 38 more clinical development and regulatory roles. Read the success story here.

Mix built a 50-person MSL team across two product launches for a global biotech, then filled 38 more clinical development and regulatory roles. Read the success story here.

An emerging gene and cell therapy startup partnered with Mix to secure key leadership for its inaugural commercial field force. The company required a national leader capable of navigating a unique and novel clinical environment.

Following an FDA approval within their rare disease portfolio, a privately owned, European life sciences organization needed a strategic partner to execute a retained search for a critical, U.S.-based VP of Analytics.

An oncology organization engaged Mix to rapidly build out their Medical Affairs leadership infrastructure with high-caliber, mission-aligned talent.

A commercial-stage pharmaceutical company engaged Mix to lead the search for a strategic leadership hire to oversee its preclinical and clinical research activities.

To support a field commercial transformation, Mix implemented an evidence-based coaching process grounded in behavioral science to activate business-critical capabilities and prepare a leadership pipeline.

Learn how Mix built a team of 104 Cardiovascular Account Specialists for a major launch, maintaining 100% retention despite shifting FDA timelines.

Mix Talent partnered with a biotech company to build a rare disease commercial team, successfully hiring 72 launch-critical roles.

Mix Talent partnered with a biotech company to build a rare disease commercial team, successfully hiring 72 launch-critical roles.

Discover how Mix Talent partnered with a global biopharma organization to build high-performing teams across key functions for a rare disease launch, filling 59 roles, from Key Account Managers to a Senior Director of HR.
When the shift from clinical to commercial begins to take shape, how you sequence your hiring decisions can be the difference between a launch that builds momentum and one that creates challenges that are difficult to unwind.
Even the most innovative treatments need the right team to succeed – unlock the talent blueprint that turns an uncertain pipeline into a revenue plan.
In an industry defined by complexity, the way organizations assemble teams needs to evolve as fast as the science they support.
Meet our 2026 Rare Heroes and join us in celebrating the remarkable individuals who are transforming the rare disease community this Rare Disease Day!
Whether you're leading talent strategy, hiring for growth, or navigating the latest workforce shifts, this report is your annual must-read guide to staying ahead.
Why mid-career life sciences talent feels harder to find - and what employers and candidates can do about it